Antiretroviral Therapy as Prevention of … Pneumococcal Infections?

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med (2015) 5.86

From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA (1993) 3.59

Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med (1992) 3.39

Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet (2009) 3.38

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med (2000) 2.85

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med (2010) 2.30

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med (2012) 2.24

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA (2011) 1.83

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2014) 1.81

Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis (2004) 1.71

Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis (2005) 1.68

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis (2005) 1.64

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med (2005) 1.50

Response to the AIDS pandemic--a global health model. N Engl J Med (2013) 1.27

Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis (2008) 1.14

The need for reappraisal of AIDS score weight of Charlson comorbidity index. J Clin Epidemiol (2007) 1.12

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS (2007) 1.11

Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis (2002) 1.11

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study. BMC Infect Dis (2011) 1.09

Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003. AIDS (2006) 1.03

Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS (2012) 1.01

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis (1996) 0.96

British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Med (2008) 0.95

Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis (2000) 0.91

Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients. Vaccine (2011) 0.84

Differences in presentation and outcome of invasive pneumococcal disease among patients with and without HIV infection in the pre-HAART era. AIDS Patient Care STDS (2005) 0.83

Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users. Clin Infect Dis (2014) 0.83

Pneumococcal infections and adult with risk factors. Med Mal Infect (2012) 0.82

[Inadequate vaccination coverage in a French cohort of HIV positive patients]. Med Mal Infect (2010) 0.78

Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era. Int J STD AIDS (2014) 0.77